{"id":7266,"date":"2018-03-06T00:00:00","date_gmt":"2018-03-05T15:00:00","guid":{"rendered":"http:\/\/shokubai.mediawars.ne.jp\/en\/?post_type=news&#038;p=7266"},"modified":"2022-10-21T18:53:00","modified_gmt":"2022-10-21T09:53:00","slug":"nippon-shokubai-announces-to-expand-the-capital-alliance-with-glytech","status":"publish","type":"news","link":"https:\/\/www.shokubai.co.jp\/en\/news\/201803067266\/","title":{"rendered":"Nippon Shokubai announces to Expand the Capital Alliance with GlyTech"},"content":{"rendered":"\n<p>NIPPON SHOKUBAI CO., LTD. (Headquarter: Osaka, Japan, President: Yujiro Goto, hereinafter \u201cNippon Shokubai\u201d) announces that Nippon Shokubai has decided additional investment to GlyTech, Inc. (Headquarter: Kyoto, Japan, President: Hiroaki Asai, hereinafter \u201cGlyTech\u201d) through a third party allotment, and completed payment procedures.<br><br>1.  Purpose of the Additional Investment<br><br>  GlyTech and Nippon Shokubai have been collaborating on research and clinical development of Glycosylated Somatostatin Analog since 2014, and Nippon Shokubai acquired the shares of GlyTech through the third-party allocation in 2015 with the aim of developing the collaboration. Through the additional investment, GlyTech and Nippon Shokubai will accelerate the collaborative research and clinical development in order to promote Glycosylated Somatostatin Analog practical. By means of it, Nippon Shokubai is supporting business development of GlyTech and working for social contribution.<br><br>2.  Outline of the Investment<br><br>Class and numbers of shares to be subscribed\t: 222,222 shares of Class B preferred stock<br>Share-holding after subscription\t\t\t: 14.03% of all issued stocks (Voting stocks)<br>Payment date\t\t\t\t\t: March 6th, 2018<br><br>3.\tOutline of GlyTech<br><br>Name            : GlyTech Inc.<br>Head Office      : 134, Chudoji Minamimachi KRP#1,Shimogyo-ku, Kyoto 600-8813, Japan<br>Representative   : Hiroaki Asai,President<br>Activity          : Licensing(glycosilated peptides and proteins),contract research and <br>development, contract manufacturing, supplying standard reagents<br>Capital           : 90 million yen<br>Established       : April 2nd, 2012<br>Numbers of shares outstanding  : 4,171,910 shares (All stocks with voting right)<br>End of fiscal year  : December 31st<br>Employees        : 21 (as of February 2018)<br>Website           : <a href=\"http:\/\/www.glytech.jp\/en\/\">http:\/\/www.glytech.jp\/en\/<\/a><br><br><br>About NIPPON SHOKUBAI Co., Ltd.: Since 1941, Nippon Shokubai has grown up its business with unique catalyst technology. Nippon Shokubai has supplied, for example, ethylene oxide, acrylic acid, automobile catalysts, process catalysts and so on. Among all, our global market share of superabsorbent polymer is the largest in the world now. Nippon Shokubai is a global chemical company operating under its corporate mission &#8220;Providing affluence and comfort to people and society with our unique technology.&#8221; <a href=\"https:\/\/www.shokubai.co.jp\/en\/\">https:\/\/www.shokubai.co.jp\/en\/<\/a><br><br>\u3010Contacts\u3011\tInvestor &amp; Public Relations Dept. <br>\tNIPPON SHOKUBAI CO., LTD.<br>\tTEL: +81-3-3506-7605\tE-mail: shokubai@n.shokubai.co.jp<br><\/p>\n\n<div class=\"cbox\">\n<!--_image_-->\n<\/div>\n\n<div id=\"file\">[Files]<br><ul><li><a href=\"\/en\/upimage\/file1_0169.pdf\" target=\"_blank\" rel=\"noopener\">Nippon Shokubai announces to Expand the Capital Alliance with GlyTech<\/a><\/li><\/ul><\/div>\n","protected":false},"excerpt":{"rendered":"<p>NIPPON SHOKUBAI CO., LTD. (Headquarter: Osaka, Japan, President: Yujiro Goto, hereinafter \u201cNippon Shokubai\u201d) a [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"menu_order":0,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"cat_news":[],"class_list":["post-7266","news","type-news","status-publish","format-standard","hentry"],"aioseo_notices":[],"acf":{"link_type":"detail","contact_info":"none","is_important":false,"is_show_top":false,"is_noindex":false},"_links":{"self":[{"href":"https:\/\/www.shokubai.co.jp\/en\/wp-json\/wp\/v2\/news\/7266"}],"collection":[{"href":"https:\/\/www.shokubai.co.jp\/en\/wp-json\/wp\/v2\/news"}],"about":[{"href":"https:\/\/www.shokubai.co.jp\/en\/wp-json\/wp\/v2\/types\/news"}],"author":[{"embeddable":true,"href":"https:\/\/www.shokubai.co.jp\/en\/wp-json\/wp\/v2\/users\/1"}],"version-history":[{"count":2,"href":"https:\/\/www.shokubai.co.jp\/en\/wp-json\/wp\/v2\/news\/7266\/revisions"}],"predecessor-version":[{"id":7642,"href":"https:\/\/www.shokubai.co.jp\/en\/wp-json\/wp\/v2\/news\/7266\/revisions\/7642"}],"wp:attachment":[{"href":"https:\/\/www.shokubai.co.jp\/en\/wp-json\/wp\/v2\/media?parent=7266"}],"wp:term":[{"taxonomy":"cat_news","embeddable":true,"href":"https:\/\/www.shokubai.co.jp\/en\/wp-json\/wp\/v2\/cat_news?post=7266"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}